Spectrum Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-2.71 | 33.49 | -108.08% | -204631.86 | -100% |
| P/S |
|
5.98 | 129.83 | -95.39% |
|
|
| P/BV |
|
2.17 | 260.15 | -99.17% |
|
|
| P/FCF |
|
-2.17 | -180.12 | -98.79% |
|
|
| Ev/Ebitda |
|
-0.6427 | -28.84 | -97.77% |
|
|
| Ev/S |
|
4.9 | 548.04 | -99.11% |
|
|
| Ev/FCF |
|
-0.5087 | -289.87 | -99.82% |
|
|
| E/P |
|
-0.3694 | 0.0228 | -1722.11% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-763.37 | -375.54 | 103.27% | -50069319.32 | -100% |
| ROE |
|
-207.06 | 106.63 | -294.19% |
|
|
| ROA |
|
-72.69 | -2.32 | 3039.86% |
|
|
| ROIC |
|
-153.71 | 0.8343 | -18524.44% |
|
|
| ROS |
|
-773.27 | -298.59 | 158.98% |
|
|
| ROCE |
|
-261.51 | 3.17 | -8343.13% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.3813 | 0.9426 | -140.45% | -0.3814 | -0.0288% |
| Nеt Debt/Ebitda |
|
0.1414 | 1.04 | -86.47% |
|
|
| Debt/Ratio |
|
0.2846 | 0.1798 | 58.32% |
|
|
| Debt/Equity |
|
2.72 | 1.62 | 67.7% |
|
|
| Debt/Net Income |
|
-0.3764 | -1.65 | -77.21% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5317 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
1 | 0.8182 | 22.22% | ||
| DSI |
|
0.5 | 0.2062 | 142.52% |
|
|
| Average dividend growth |
|
0 | 2.29 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5169 | -100% |
|
|
| Average percentage for payments |
|
9.53 | 58.77 | -83.78% |
|
|
| Difference from average difference in sector |
|
-0.5317 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
14.16 | -99.58 | -114.22% | ||
| Growth impulse Ebitda in 5 years |
|
-56.01 | -152.61 | -63.3% | ||
| Growth impulse Net Income in 5 years |
|
-52.07 | -115.25 | -54.82% | ||
| Growth impulse FCF in 5 years |
|
-38.37 | -161.2 | -76.2% | ||
| Growth impulse EPS in 5 years |
|
-74.08 | -106.31 | -30.32% |
IP Score
3.12/10
